Lilly Hungária
Lilly Hungária is the Hungarian operating subsidiary of Eli Lilly and Company, marketing prescription pharmaceuticals across diabetes, oncology, immunology, pain management, and neurodegeneration, plus medical devices, to Hungarian healthcare providers and patients.
- Company typePrivate
- Founded1990
- HeadquartersBudapest, Hungary
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
Lilly Hungária firmographics
Firmographics- Name
- Lilly Hungária
- Legal name
- Lilly Hungária
- Website
- https://lilly.hu
- Company type
- Private
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Lilly Hungária is the Hungarian operating subsidiary of Eli Lilly and Company, marketing prescription pharmaceuticals across diabetes, oncology, immunology, pain management, and neurodegeneration, plus medical devices, to Hungarian healthcare providers and patients.
- Ownership category
- akta.pro rank
Where Lilly Hungária is headquartered
LocationHeadquarters
- HQ city
- Budapest
- HQ country
- Hungary
- HQ region
- Europe
Markets served
Lilly Hungária business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Lilly Hungária product offering
Product offeringCore offering
Lilly Hungária is the Hungarian subsidiary of Eli Lilly and Company, focused on developing, marketing, and distributing prescription pharmaceutical medicines and medical devices in Hungary. Its portfolio covers five therapeutic areas: Diabetes, Oncology (malignant tumors), Immunology, Pain Management, and Neurodegeneration. The company combines care with scientific discovery to deliver innovative medicines that improve patient outcomes in serious and chronic conditions.
Differentiator
Problem solved
Functional benefit
Products and services
- Diabetes medicines
- Oncology (malignant tumor) medicines
- Immunology medicines
- Pain management medicines
- Neurodegeneration medicines
- Medical devices (orvostechnikai eszközök)
Companies that use Lilly Hungária
Customer profileSegments1 record
Ideal customer profiles1 record
Lilly Hungária technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Lilly Hungária competitors and assessment
Company assessmentDirect peers
- MSD Hungary: Hungarian subsidiary of Merck & Co. (known as MSD in Europe). Comparable as a US-major pharma subsidiary with similar oncology, immunology, and chronic disease portfolio operating in the same Hungarian market.
- AstraZeneca Hungary: Hungarian subsidiary of the UK/Swedish pharmaceutical major AstraZeneca. Comparable as a global pharma subsidiary with strong oncology and biologics presence operating in the same Hungarian market with similar prescription drug distribution model.
- Takeda Hungary: Hungarian subsidiary of the Japanese pharmaceutical major Takeda. Comparable as a global pharma subsidiary with notable presence in oncology, gastroenterology, and rare disease areas operating in the same Hungarian market.
- Novartis Hungary: Hungarian subsidiary of the Swiss pharmaceutical major Novartis. Directly comparable as a multinational pharma subsidiary operating in the same Hungarian market with similar therapeutic-area breadth and prescription drug distribution model.
- Bayer Hungary: Hungarian subsidiary of the German life sciences major Bayer. Comparable as a multinational pharmaceutical and life sciences subsidiary distributing prescription medicines in the same Hungarian market across overlapping therapeutic areas.
- Pfizer Hungary: Pfizer's Hungarian subsidiary, operating as a pharmaceutical company distributing prescription medicines across multiple therapeutic areas. Directly comparable to Lilly Hungária as a US-major pharma subsidiary in the same single market with parallel marketing and distribution functions.
- Johnson & Johnson Hungary (Janssen): Hungarian subsidiary of Johnson & Johnson's pharma arm (Janssen). Comparable as a multinational pharma subsidiary with overlapping therapeutic focus areas (oncology, immunology, neurology) operating through parallel channels in Hungary.
- Sanofi Hungary: Hungarian subsidiary of the French pharmaceutical major Sanofi. Comparable as a multinational pharma subsidiary distributing prescription medicines across diabetes, immunology, oncology, and rare disease areas in the same single market.
- Roche Hungary: Hungarian subsidiary of the Swiss pharmaceutical and diagnostics major Roche. Comparable as a global pharma subsidiary with overlapping therapeutic areas (oncology in particular) operating in the same Hungarian market with parallel distribution channels.
- GSK Hungary: Hungarian subsidiary of the UK pharmaceutical major GSK. Comparable as a multinational pharma subsidiary with overlapping focus on immunology, oncology, and chronic disease therapy areas operating in the same Hungarian market.
Market position
Customer concentration
Lilly Hungária financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lilly Hungária leadership team
Management profileNumber of profiles
Lilly Hungária funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lilly Hungária M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lilly Hungária
What does Lilly Hungária do?
Lilly Hungária is the Hungarian subsidiary of Eli Lilly and Company, focused on developing, marketing, and distributing prescription pharmaceutical medicines and medical devices in Hungary. Its portfolio covers five therapeutic areas: Diabetes, Oncology (malignant tumors), Immunology, Pain Management, and Neurodegeneration. The company combines care with scientific discovery to deliver innovative medicines that improve patient outcomes in serious and chronic conditions.
Is Lilly Hungária a public or private company?
Lilly Hungária is a private company. It is classified as corporate owned and is currently operating.
When was Lilly Hungária founded?
Lilly Hungária was founded in 1990. It employs 51 to 100 people.
Where is Lilly Hungária based?
Lilly Hungária is headquartered in Budapest, Hungary, in the Europe region.
Who are Lilly Hungária's main competitors?
Direct peers on record are MSD Hungary, AstraZeneca Hungary, Takeda Hungary, Novartis Hungary, Bayer Hungary, Pfizer Hungary, Johnson & Johnson Hungary (Janssen), Sanofi Hungary, Roche Hungary and GSK Hungary.
Does Lilly Hungária have an API?
No public API is recorded for Lilly Hungária.